Tier 2 — strong

Targeting the Hallmarks of Aging with Vitamin D: Starting to Decode the Myth

Carmelinda Ruggiero, Laura Tafaro, Luisella Cianferotti, Flavia Tramontana, Ilaria Giovanna Macchione, Carla Caffarelli, Agostino Virdis, Marika Ferracci, Giuseppe Rinonapoli, Patrizia Mecocci, Nicola Napoli, Valeria Calsolaro
Nutrients 2024 Volume 16, page 906

Bibliography

PubMed
PMID 38542817
PubMed Central
PMC10975458
DOI
10.3390/nu16060906
Video explainer
Watch on YouTube Biohack Blueprint's video walkthrough of this study.
Funding
This research received no external funding.
Competing interests
The authors declare no conflict of interest.

Study snapshot

DesignNarrative review of human clinical and preclinical evidence.
ModelReview spanning human subjects, in vitro cell lines, and animal models across twelve hallmarks of aging.
SampleReview of multiple clinical and preclinical cohorts (e.g., VITAL study sub-cohort of 25,871 participants, Twins UK cohort of 2160 women).
InterventionVitamin D supplementation across various continuous and intermittent dosing paradigms (e.g., 800 IU/day to 5000 IU/day).
DurationAnalyzes various study lengths ranging from short-term acute supplementation to multi-year longitudinal follow-ups.
EndpointsBiomarkers of the hallmarks of aging, including genomic damage, leukocyte telomere length, DNA methylation, senescence-associated secretory phenotype (SASP) markers, inflammatory cytokines (IL-6, hs-CRP), and gut microbiota composition.

What the study showed, in plain terms

Aging is driven by twelve interconnected biological mechanisms—known as the "hallmarks of aging"—which lead to cellular damage and increase the risk of age-related diseases. Vitamin D, while widely known for its benefits to bone and muscle health, acts on many other tissues in the body through Vitamin D Receptors (VDRs). This review explores whether Vitamin D can target these underlying aging mechanisms to promote healthy aging and delay physical decline.

The authors analyzed existing human clinical trials and preclinical studies to see how Vitamin D influences each of the twelve aging hallmarks. While the evidence is still developing, findings suggest that Vitamin D may help protect DNA stability, positively influence genetic expression (epigenetics), and reduce chronic inflammation and cellular senescence. It also appears to support a healthy gut microbiome, which is often disrupted in aging and chronic inflammatory conditions.

Despite these promising biological effects, the review highlights that the current evidence in humans is limited. Large, long-term human studies are still needed to confirm if Vitamin D supplementation can directly slow the aging process or prevent age-related diseases. For now, maintaining adequate Vitamin D levels remains crucial for overall health and preventing deficiencies that accelerate age-related physical and immune decline.

Key findings

  • Vitamin D supplementation in older adults and patients with metabolic disorders reduced oxidative DNA damage and promoted genomic stability.
  • Epigenetic studies showed that Vitamin D supplementation lowered DNA methylation and slowed epigenetic aging in specific populations, such as overweight African American women.
  • Clinical trials demonstrated mixed results regarding telomere length; while some cohorts showed positive correlations between serum Vitamin D and telomere length, Mendelian randomization studies did not support a direct causal effect.
  • Vitamin D supplementation (2000 IU/day) in the VITAL study (n=25,871) decreased high-sensitivity C-reactive protein (hs-CRP) by 19% at year 2, though this reduction was attenuated by year 4.
  • Immunomodulatory effects were observed in frail older adults, where alphacalcidol supplementation improved T-cell subsets and inflammatory profiles (CD4/CD8 ratio, IL-6).
  • Evidence indicates that Vitamin D deficiency contributes to gut dysbiosis, and supplementation can significantly increase health-promoting gut probiotics while reducing potentially pathogenic species.

What this study can and cannot tell us

This is a narrative review, not a systematic review or meta-analysis. The authors did not use formal statistical pooling of data, so conclusions should be treated as an informed synthesis rather than a quantitative summary.

Many of the human studies analyzed were cross-sectional, underpowered, or focused on specific disease subsets, making it difficult to establish direct causality or identify optimal dosages for anti-aging benefits across the general population.

A significant portion of the mechanistic insights—such as effects on proteostasis, mitochondrial dysfunction, and stem cell exhaustion—comes from preclinical animal or in vitro models. These biological responses do not always translate directly to human physiology.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology